Menu
Dr. Jason McKeown, MD PhD is a UK-trained medical doctor who specialises in non-invasive neurostimulation. Through his work in the field of neuroscience and interest in advanced technology, he believes there is a better way to treat diseases affecting the lives of people worldwide. His dedication to advancing medical technology, combined with his deep understanding of mental health disorders has positioned him as a trailblazer in the field.
After years of research and development, Dr. McKeown led the Neurovalens team through a successful study into the effectiveness of the Modius Sleep device on the treatment of chronic insomnia, resulting in Medical Device Regulatory Approval via FDA 510(k) clearance in October 2023. In March 2024, Neurovalens also received FDA clearance for Modius Calm, a treatment for anxiety.
Dr. McKeown holds academic appointments in theDepartment of Psychiatry at University of California, San Diego (UCSD), and in the Department of Neurosurgery at Stanford University. Dr. McKeown is a member of the General Medical Council and has worked within the National Health Service (NHS) in the UK. Dr McKeown is also a member of the Society for Neuroscience, the Royal College of Emergency Medicine, the Association of British Neurologists, the Royal College of Physicians and The Society for Neuroscience.
Keep up to date with our latest products, research and company news.
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
Our medical device technology offers unparalleled transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus, allowing for alterations in autonomic function, circadian regulation and Neuro-metabolic influence.
